BriaCell Therapeutics Corp. (BCTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BriaCell Therapeutics Cor...

    NASDAQ: BCTX · Real-Time Price · USD
    13.08
    0.25 (1.95%)
    At close: Oct 03, 2025, 3:59 PM
    13.31
    1.74%
    Pre-market: Oct 06, 2025, 07:02 AM EDT

    BriaCell Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is August - July.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jul 31, 2024 Jul 31, 2023 Jul 31, 2022 Jul 31, 2021
    PE Ratio
    		 -18.72K -51.47 -85.76 -79.31
    PEG Ratio
    		 238.89 2.24 1.91 2.00
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 -51.99 -276.65 96.15 4.01
    P/FCF Ratio
    		 -5.04 -44.01 -79.55 -29.63
    P/OCF Ratio
    		 -5.13 -44.01 -79.55 -29.63
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a 0.00
    Quick Ratio
    		 0.49 11.81 45.00 102.88
    Current Ratio
    		 0.49 14.96 45.00 103.81
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -15.62K -151.27
    Return on Equity
    		 n/a 5.37 -1.12 -0.05
    Return on Assets
    		 n/a -0.75 -0.27 -0.05
    Return on Invested Capital
    		 0.03 -0.91 -0.37 -0.18
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist